Refine by
Molecular Diagnostic Software
7 software items found
Manufactured by:Mammoth Biosciences, Inc. based inBrisbane, CALIFORNIA (USA)
The CRISPR-based detection platform: Our revolutionary method for molecular diagnostics, enabling limitless testing ...
Manufactured by:Fusion Genomics Corporation based inBurnaby, BRITISH COLUMBIA (CANADA)
It is a secure and compliant bioinformatics platform for sensitive and multiplexed pathogen identification from (NGS) data generated by the ONETest molecular diagnostic assay ...
Manufactured by:DNAiTECH Ltd based inBlenheim, NEW ZEALAND
DNAiTECH is advancing the field of in-field and point-of-care diagnostics with the development of innovative testing instruments. Their Gen3 platform, slated for release in 2024, aims to meet the World Health Organization's ASSURED criteria, encompassing affordability, sensitivity, user-friendliness, and robustness, among other factors. This platform incorporates microfluidics ...
Manufactured by:Mammoth Biosciences, Inc. based inBrisbane, CALIFORNIA (USA)
Discovering novel CRISPR systems: We are addressing the current challenges of CRISPR-Cas systems and expanding the scope of use by applying our proprietary discovery platform to identify novel Cas ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Clinical interpretation has been one of the most complex and time-consuming aspects of transforming genomic data into meaningful results, until ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Identifying patterns of genomic scarring in ovarian cancer samples. Accurate identification and reporting of Homologous Recombination Deficiency (HRD) status are critical for better patient management. SOPHiA DDM Dx HRD Solution is a CE-marked in vitro diagnostic (IVD) application leveraging low-pass Whole Genome Sequencing (WGS) and a proprietary deep-learning algorithm. Powered by the advanced ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Enabling novel fusion detection in small samples to improve lung cancer management. Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a CE-marked in vitro diagnostic (IVD) application based on next-generation sequencing (NGS) enabling accurate and sensitive detection of novel ...